Estrogen-induced GPCR is crucial in the osteogenic axis, as it activates the ERK1/2 and PI3K–Akt signaling pathways to promote mitophagy in osteoblasts and reduce osteoblast apoptosis, thereby reversing osteoporosis [54,58,59]. The gene discussed is AKT1; the disease is osteoporosis.